Gambaran Umum
Labiana Life Sciences S.A. is a pharmaceutical company primarily focusing on developing, manufacturing, and marketing pharmaceutical products for both human and veterinary use. Established in 1957, the company has two production plants in Spain and operates in more than 80 countries worldwide. Key projects include the development of innovative pharmaceutical solutions in oncology, cardiology, and central nervous system disorders for human health. For veterinary health, Labiana focuses on creating new vaccines and medicines for pets and livestock. The company's commitment to quality and innovation has positioned it as a significant player in the global pharmaceutical industry.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Labiana Health, S.A. per 2024 Dec 31 adalah 67.37 MM.
- Nilai operating income untuk Labiana Health, S.A. per 2024 Dec 31 adalah 5.08 MM.
- Nilai net income untuk Labiana Health, S.A. per 2024 Dec 31 adalah 0.25 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2024-12-31 | 67.37 | 5.08 | 0.25 |
| 2024-09-30 | 66.76 | 4.40 | -0.46 |
| 2024-06-30 | 66.14 | 3.71 | -1.18 |
| 2024-03-31 | 62.92 | 0.89 | -2.80 |
| 2023-12-31 | 59.70 | -1.92 | -4.42 |
| 2023-09-30 | 59.88 | -2.95 | -6.99 |
| 2023-06-30 | 60.05 | -3.98 | -9.57 |
| 2023-03-31 | 60.41 | -3.10 | -9.25 |
| 2022-12-31 | 60.76 | -2.23 | -8.94 |
| 2021-12-31 | 59.44 | 0.61 | -1.78 |
| 2020-12-31 | 60.10 | 1.95 | 1.07 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | -0.17 | -0.17 |
| 2024-03-31 | -0.40 | -0.40 |
| 2023-12-31 | -0.63 | -0.63 |
| 2023-09-30 | -0.99 | -0.99 |
| 2023-06-30 | ||
| 2023-03-31 | -1.30 | -1.30 |
| 2022-12-31 | ||
| 2021-12-31 | -0.29 | -0.29 |
| 2020-12-31 | 0.17 | 0.17 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Labiana Health, S.A. per 2024 Dec 31 adalah 7.19 MM.
- Nilai cash from investing activities untuk Labiana Health, S.A. per 2024 Dec 31 adalah -3.99 MM.
- Nilai kas dari aktivitas pendanaan untuk Labiana Health, S.A. per 2024 Dec 31 adalah 0.57 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2024-12-31 | 7.19 | -3.99 | 0.57 |
| 2024-09-30 | 2.78 | -3.03 | 3.26 |
| 2024-06-30 | -1.63 | -2.08 | 5.96 |
| 2024-03-31 | -1.73 | -2.06 | 5.13 |
| 2023-12-31 | -1.83 | -2.03 | 4.30 |
| 2023-09-30 | 3.68 | -3.95 | -1.70 |
| 2023-06-30 | 9.19 | -5.86 | -7.69 |
| 2023-03-31 | 6.93 | -4.40 | -5.09 |
| 2022-12-31 | 4.68 | -2.95 | -2.50 |
| 2021-12-31 | 3.91 | -7.23 | 5.06 |
| 2020-12-31 | 3.79 | -7.26 | 2.90 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2021-12-31 | |||
| 2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2021-12-31 | ||
| 2020-12-31 |
Efektivitas Manajemen
- roa untuk Labiana Health, S.A. pada 2024 Dec 31 adalah -0.02.
- roe untuk Labiana Health, S.A. pada 2024 Dec 31 adalah 0.07.
- roic untuk Labiana Health, S.A. pada 2024 Dec 31 adalah -0.03.
- croic untuk Labiana Health, S.A. pada 2024 Dec 31 adalah 0.06.
- ocroic untuk Labiana Health, S.A. pada 2024 Dec 31 adalah -0.04.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2024-12-31 | -0.02 | 0.07 | -0.03 | 0.06 | -0.04 |
| 2024-09-30 | -0.01 | -0.14 | |||
| 2024-06-30 | -0.08 | -0.60 | -0.10 | 0.01 | -0.04 |
| 2024-03-31 | -0.16 | -1.39 | |||
| 2023-12-31 | 0.00 | ||||
| 2023-09-30 | -0.23 | -0.11 | 0.22 | ||
| 2023-06-30 | -0.14 | -0.83 | -0.16 | -0.07 | 0.16 |
| 2023-03-31 | -0.14 | -0.80 | -0.16 | -0.04 | 0.12 |
| 2022-12-31 | 0.00 | 0.00 | 0.00 | ||
| 2021-12-31 | |||||
| 2020-12-31 | 0.02 | 0.08 |
Gross Margins
- marjin kotor untuk Labiana Health, S.A. pada 2024 Dec 31 adalah 0.58.
- marjin bersih untuk Labiana Health, S.A. pada 2024 Dec 31 adalah -0.02.
- marjin operasi untuk Labiana Health, S.A. pada 2024 Dec 31 adalah 0.06.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2024-12-31 | 0.58 | -0.02 | 0.06 |
| 2024-09-30 | 0.55 | -0.07 | -0.03 |
| 2024-06-30 | 0.55 | -0.07 | -0.03 |
| 2024-03-31 | 0.49 | -0.16 | -0.07 |
| 2023-12-31 | |||
| 2023-09-30 | 0.49 | -0.16 | -0.07 |
| 2023-06-30 | 0.49 | -0.16 | -0.07 |
| 2023-03-31 | 0.50 | -0.15 | -0.05 |
| 2022-12-31 | |||
| 2021-12-31 | |||
| 2020-12-31 | 0.57 | 0.02 | 0.04 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) |
Grupong Pang-industriya
| SIC 8721 - Accounting, Auditing, and Bookkeeping Services |
